| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | Canada | 2 | |
| #3 | Argentina | 1 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | China | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | Taiwan | 1 | |
| #11 | United States | 1 | |
| #12 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Syringes | |
| #4 | Medical purpose containers |
| # | Name | Total Patents |
|---|---|---|
| #1 | Violante Michael R | 12 |
| #2 | Curry Stephen H | 7 |
| #3 | Brown Rodney A | 7 |
| #4 | Rubenstein Michael | 5 |
| #5 | Holt Kris | 3 |
| #6 | Thassu Deepak | 3 |
| #7 | Kuo Youti | 2 |
| #8 | Rubinstein Michael | 2 |
| #9 | Michael Rubenstein | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2011268775A1 | Nanoparticle pharmaceutical formulations | |
| CN101137352A | Pharmaceutical formulations and methods of use |